HALOZYME THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+22.7% +$41M
$219M
Free Cash Flow↑+24.0% +$42M
$218M
Investing Cash Flow
$202M
Financing Cash Flow
$240M